Sedation Reversal

Sedation Reversal is a pharmacological intervention that belongs to the class of antidotal therapies and is specifically characterized by the targeted antagonism of benzodiazepine-induced central nervous system depression through the competitive inhibition of benzodiazepine receptors, as exemplified by the administration of flumazenil.

109

Publications

3.9K

Citations

406

Authors

156

Institutions

Publications per year

2017–2026

6

Authors

406

  1. DN
    David Niv

    Tel Aviv Sourasky Medical Center, Israel

    3 publications · 58 citations

    3

    h-index

  2. PF
    Paul F. White

    The University of Texas Southwestern Medical Center, United States

    3 publications · 177 citations

    3

    h-index

  3. JB
    Jeffrey B. Gross

    University of Connecticut, United States

    3 publications · 138 citations

    3

    h-index

  4. JM
    Janet Moss

    Christ Hospital, United States

    2 publications · 31 citations

    2

    h-index

  5. MM
    Mohammed M. Ghoneim

    Almaarefa University

    2 publications · 50 citations

    2

    h-index

1–5 of 406

Venues

  1. PubMed

    Repository · 16 publications · 494 citations

    13

    h-index

  2. Anesthesiology

    8 publications · 345 citations

    8

    h-index

  3. Acta Anaesthesiologica Scandinavica

    7 publications · 318 citations

    7

    h-index

  4. Anesthesia & Analgesia

    7 publications · 312 citations

    7

    h-index

  5. British Journal of Anaesthesia

    4 publications · 127 citations

    4

    h-index

1–5